Document

Drug delivery of carvedilol (cardiovascular drug) using phosphorene as a drugcarrier : a DFT study

Author
Linked Agent
Afzal, Q.Q, Author
Perveen, M, Author
Iqbal, J, Author
Akhter, M.S, Author
Nazir, S, Author
Alomairy, S, Author
Title of Periodical
Journal of Taibah University for Science
Country of Publication
Kingdom of Bahrain
Place Published
Sakhir, Bahrain
Publisher
University of Bahrain
Date Issued
2022
Language
English
English Abstract
ABSTRACT: 2D nanomaterial phosphorene is a chemistically stable, biocompatible, and biodegradable drug delivery platform. This study investigates the drug loading efficiency of phosphorene for the car-diovascular drug carvedilol using density-functional theory (DFT). In the gas phase, carvedilol prefers to interact with phosphorene via P-H bonding with an adsorption energy of 0.59 eV (0.45eV in water). The complex HOMO–LUMO energy gap has been calculated in gas and solvent media to assess phosphorene-carvedilol reactivity. As compared to free carvedilol and phos-phorene, the phosphorene-carvedilol complex has increased solubility. The NCI analysis visu-alises non-covalent interactions within complexes. The low Van der Waals interactions between carvedilol and phosphorene allow for easy drug offloading. The phosphorene-carvedilol com-plex is more soluble in water than previously thought. Phosphorene’s electron density changes significantly after complex formation, as revealed by charge decomposition plots and electron-localization function plots. PET (photo-induced electron transfer) analysis explains quenching.
Member of
Identifier
https://digitalrepository.uob.edu.bh/id/4955f492-4408-4366-9622-f6fef612f1df